Evidence map›Paper›PMID 35301383›Full record

ArticleScientific reports2022

Effect of serum sample storage temperature on metabolomic and proteomic biomarkers.

Erkka Valo, Marco Colombo, Niina Sandholm, Stuart J McGurnaghan, Luke A K Blackbourn, David B Dunger, Paul M McKeigue, Carol Forsblom, Per-Henrik Groop, Helen M Colhoun and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Erkka Valo *Folkhälsan Institute of Genetics, Folkhälsan Research Center, 00290, Helsinki, Finland.
Marco Colombo *The Usher Institute, University of Edinburgh, Edinburgh, UK.
Niina SandholmFolkhälsan Institute of Genetics, Folkhälsan Research Center, 00290, Helsinki, Finland.
Stuart J McGurnaghanThe Usher Institute, University of Edinburgh, Edinburgh, UK.
Luke A K BlackbournInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
David B DungerDepartment of Paediatrics, University of Cambridge, Cambridge, UK.
Paul M McKeigueThe Usher Institute, University of Edinburgh, Edinburgh, UK.
Carol ForsblomFolkhälsan Institute of Genetics, Folkhälsan Research Center, 00290, Helsinki, Finland.
Per-Henrik GroopFolkhälsan Institute of Genetics, Folkhälsan Research Center, 00290, Helsinki, Finland. per-henrik.groop@helsinki.fi.
Helen M ColhounInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. helen.colhoun@ed.ac.uk.
Charles TurnerWellChild Laboratory, Evelina London Children's Hospital, Guy's and St Thomas' National Health Service Foundation Trust, London, UK.
R Neil DaltonWellChild Laboratory, Evelina London Children's Hospital, Guy's and St Thomas' National Health Service Foundation Trust, London, UK. neil.dalton@gstt.nhs.uk.

Funding

Chief Scientist Office ETM/47Chief Scientist Office Ref. ETM/47
6 · The paper itself

Abstract

Prospective biomarker studies can be used to identify biomarkers predictive of disease onset. However, if serum biomarkers are measured years after their collection, the storage conditions might affect analyte concentrations. Few data exists concerning which metabolites and proteins are affected by storage at - 20 °C vs - 80 °C. Our objectives were to document analytes affected by storage of serum samples at - 20 °C vs - 80 °C, and to identify those indicative of the storage temperature. We utilized liquid chromatography tandem mass spectrometry and Luminex to quantify 300 analytes from serum samples of 16 Finnish individuals with type 1 diabetes, with split-aliquot samples stored at - 80 °C and - 20 °C for a median of 4.2 years. Results were validated in 315 Finnish and 916 Scottish individuals with type 1 diabetes, stored at - 20 °C and at - 80 °C, respectively. After quality control, we analysed 193 metabolites and proteins of which 120 were apparently unaffected and 15 clearly susceptible to storage at - 20 °C vs - 80 °C. Further, we identified serum glutamate/glutamine ratio greater than 0.20 as a biomarker of storage at - 20 °C vs - 80 °C. The results provide a catalogue of analytes unaffected and affected by storage at - 20 °C vs - 80 °C and biomarkers indicative of sub-optimal storage.

Indexed as

Diabetes Mellitus, Type 1ProteomicsBiomarkersHumansProspective StudiesTemperatureBiomarkers

Identifiers

PMID35301383
PMCPMC8930974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.